Table 1 Clinical data and outcome of patients with invasive aspergillosis in Shiraz, Iran
From: Role of biomarkers in the diagnosis of invasive aspergillosis in immunocompromised patients
Frequency | Percent | |
|---|---|---|
Sex | ||
Male | 22 | 64.7 |
Female | 12 | 35.3 |
Back ground | ||
Hematologic Disorder | 29 | 85.3 |
Transplant | 2 | 5.9 |
Combined Immunodeficiency | 3 | 8.8 |
Site of infection | ||
Lung | 11 | 32.3 |
Blood (FUO⁕) | 10 | 29.4 |
Liver | 6 | 17.7 |
Heart | 1 | 2.9 |
Kidney | 2 | 5.9 |
Sinuses | 2 | 5.9 |
Central nervous system | 2 | 5.9 |
Outcome | ||
Lived | 22 | 64.7 |
Dead | 12 | 35.3 |